Articles by Peter Pitts - Pharmaceutical Executive

ADVERTISEMENT

Articles by Peter Pitts

If It Walks Like a Duck

Aug 1, 2009

Dietary supplements function like drugs and are marketed like drugs. They should be regulated like ducks.

Fewer Cents, More Sense

Our healthcare system may be broken, but playing the blame game is not going to fix it. Remember that disease—not Big Pharma—is the enemy.
Jul 30, 2007

The US healthcare system may be broken, as such sages as Michael Moore suggest, but it's not likely to be fixed as long as our domestic debate remains stuck on the cost of prescription drugs. Meanwhile, obesity and diabetes are becoming national epidemics. Talk about sicko.

Opinion: Are Price Controls the New Black?

A revamped version of an old bill calling for drug importation is on the congressional runway. With bipartisan backing and red-hot Rahmed-up rhetoric, the legislation might just pass—and spell failure for the future of innovative drug development.
May 1, 2007

In march, us rep. rahm "Mr. Television" Emanuel (D-IL) reintroduced legislation aimed at what he calls "driving down the price of prescription drugs." But the only thing such legislation would accomplish would be the "driving down" of pharmaceutical innovation.

Opinion: The Media Attacks Ghostwritten Articles

Feb 1, 2006

Attacking articles in medical journals, those ghostwritten by professional medical writers paid by pharmaceutical companies, is the media's latest attempt to taint anything supported, promoted, or approved by Big Pharma.

Opinion: It's All Relative

PhRMA's new voluntary guidelines are about much more than DTC advertising—and they're not really voluntary.
Nov 1, 2005

PhRMA Guiding Principle number 10 calls for the banishment of reminder ads. While there are many reasons why drug ads truly advance the public health, there are no good arguments for why reminder ads advance public health in any way.

ADVERTISEMENT

Click here